Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 7-Day Trial for You or Your Team.

Learn More →

DSM-5

DSM-5 COMMENTARY DSM-5 Somatic Symptom Disorder Allen Frances, MD n a previous article (Frances and Chapman, 2013), I indicated that the very inclusive Diagnostic Iand Statistical Manual of Mental Disorders, Fifth Edition (DSM-5), definition of somatic symptom disorder (SSD) would capture a whopping 15% of patients with cancer and heart disease and 25% of patients with irritable bowel syndrome and chronic widespread pain and would have a 7% false- positive rate in the general population (Dimsdale, 2012). A second article spelled out the consider- able risks to medically ill people who are mislabeled (Frances and Chapman, in press). My purpose here was to indicate how the loose DSM-5 SSD criteria set could (and should) have been tightened and to speculate on why it was not. The DSM-5 work group, charged with revising the somatoform disorders in DSM-IV, started its deliberations with two stated goals: a) to de-emphasize the central role of medically unexplained symptoms in defining SSD and b) to respond to the fact that the DSM-IV section on somatoform disorders was rarely used in clinical practice. It was no surprise that the work group wanted to expand the inclusiveness and purview of its section. Experts in any area of http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png The Journal of Nervous and Mental Disease Wolters Kluwer Health

DSM-5

Download PDF
2 pages

Loading next page...
 
/lp/wolters-kluwer-health/dsm-5-xoc89Ted4v

References

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

Copyright
Copyright © 2013 by Lippincott Williams & Wilkins
ISSN
0022-3018
eISSN
1539-736X
DOI
10.1097/NMD.0b013e318294827c
pmid
23719325
Publisher site
See Article on Publisher Site

Abstract

COMMENTARY DSM-5 Somatic Symptom Disorder Allen Frances, MD n a previous article (Frances and Chapman, 2013), I indicated that the very inclusive Diagnostic Iand Statistical Manual of Mental Disorders, Fifth Edition (DSM-5), definition of somatic symptom disorder (SSD) would capture a whopping 15% of patients with cancer and heart disease and 25% of patients with irritable bowel syndrome and chronic widespread pain and would have a 7% false- positive rate in the general population (Dimsdale, 2012). A second article spelled out the consider- able risks to medically ill people who are mislabeled (Frances and Chapman, in press). My purpose here was to indicate how the loose DSM-5 SSD criteria set could (and should) have been tightened and to speculate on why it was not. The DSM-5 work group, charged with revising the somatoform disorders in DSM-IV, started its deliberations with two stated goals: a) to de-emphasize the central role of medically unexplained symptoms in defining SSD and b) to respond to the fact that the DSM-IV section on somatoform disorders was rarely used in clinical practice. It was no surprise that the work group wanted to expand the inclusiveness and purview of its section. Experts in any area of

Journal

The Journal of Nervous and Mental Disease – Wolters Kluwer Health

Published: Jun 1, 2013

There are no references for this article.